Nitrogen-containing bisphosphonate for vascular calcification: animal experiments, systematic review and meta-analysis

Abstract Background The purpose of our study was to explore the effect of nitrogen-containing bisphosphonate (N-BP) on vascular calcification (VC) through animal experiments and a meta-analysis. Methods In our animal experiments, Sprague-Dawley (SD) rats were randomly divided into a control group, a...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Xu, Guoyuan Lu, Lifeng Gong, Weigang Tang, Wei Jiang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-025-04526-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832572037572329472
author Wei Xu
Guoyuan Lu
Lifeng Gong
Weigang Tang
Wei Jiang
author_facet Wei Xu
Guoyuan Lu
Lifeng Gong
Weigang Tang
Wei Jiang
author_sort Wei Xu
collection DOAJ
description Abstract Background The purpose of our study was to explore the effect of nitrogen-containing bisphosphonate (N-BP) on vascular calcification (VC) through animal experiments and a meta-analysis. Methods In our animal experiments, Sprague-Dawley (SD) rats were randomly divided into a control group, a VC group, a low-dose zoledronic acid (ZOL) (20 µg/kg) group and a high-dose ZOL (100 µg/kg) group. The calcification of the aortic arch was observed by alizarin red staining. The calcium content of the aortic arch was measured. In our systematic review and meta-analysis, databases, including PubMed, Embase, the Cochrane Library, China National Knowledge Infrastructure (CNKI), and the Wanfang database, were searched from their inception to December 20, 2023. Eligible studies comparing N-BP versus no N-BP in the treatment of VC were included. Results In our animal experiment, the red-stained calcification structure in the low-dose ZOL group was slightly reduced and the red-stained calcification structure in the high-dose ZOL group was significantly reduced compared with that in the VC. The calcium content in the low-dose ZOL group was slightly lower than that in the VC group, but the difference was not significant (P = 0.08). The calcium content in the high-dose ZOL group was significantly lower than that in the VC group (P < 0.0001). Our meta-analysis of human studies revealed that N-BP did not reduce the arterial calcification score (P = 0.46). Our meta-analysis of animal studies revealed that N-BP did not significantly reduce the arterial calcification score (P = 0.09), but N-BP reduced the arterial calcification area (P < 0.00001), arterial calcium content (P = 0.009) and PO4 content (P = 0.0001). Conclusions Our animal experiment revealed that high-dose ZOL inhibited VC, but low-dose ZOL did not significantly inhibit VC. Our meta-analysis of human studies revealed that N-BP was not effective in the treatment of VC, but our meta-analysis of animal studies suggested a role of N-BP in inhibiting VC.
format Article
id doaj-art-e908c6cbc74242e9be5d754455033891
institution Kabale University
issn 1471-2261
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj-art-e908c6cbc74242e9be5d7544550338912025-02-02T12:07:37ZengBMCBMC Cardiovascular Disorders1471-22612025-01-012511910.1186/s12872-025-04526-wNitrogen-containing bisphosphonate for vascular calcification: animal experiments, systematic review and meta-analysisWei Xu0Guoyuan Lu1Lifeng Gong2Weigang Tang3Wei Jiang4Department of Nephrology, The Wujin Clinical College of Xuzhou Medical UniversityDepartment of Nephrology, The First Affiliated Hospital of Soochow UniversityDepartment of Nephrology, The Wujin Clinical College of Xuzhou Medical UniversityDepartment of Nephrology, The Wujin Clinical College of Xuzhou Medical UniversityDepartment of Nephrology, The Wujin Clinical College of Xuzhou Medical UniversityAbstract Background The purpose of our study was to explore the effect of nitrogen-containing bisphosphonate (N-BP) on vascular calcification (VC) through animal experiments and a meta-analysis. Methods In our animal experiments, Sprague-Dawley (SD) rats were randomly divided into a control group, a VC group, a low-dose zoledronic acid (ZOL) (20 µg/kg) group and a high-dose ZOL (100 µg/kg) group. The calcification of the aortic arch was observed by alizarin red staining. The calcium content of the aortic arch was measured. In our systematic review and meta-analysis, databases, including PubMed, Embase, the Cochrane Library, China National Knowledge Infrastructure (CNKI), and the Wanfang database, were searched from their inception to December 20, 2023. Eligible studies comparing N-BP versus no N-BP in the treatment of VC were included. Results In our animal experiment, the red-stained calcification structure in the low-dose ZOL group was slightly reduced and the red-stained calcification structure in the high-dose ZOL group was significantly reduced compared with that in the VC. The calcium content in the low-dose ZOL group was slightly lower than that in the VC group, but the difference was not significant (P = 0.08). The calcium content in the high-dose ZOL group was significantly lower than that in the VC group (P < 0.0001). Our meta-analysis of human studies revealed that N-BP did not reduce the arterial calcification score (P = 0.46). Our meta-analysis of animal studies revealed that N-BP did not significantly reduce the arterial calcification score (P = 0.09), but N-BP reduced the arterial calcification area (P < 0.00001), arterial calcium content (P = 0.009) and PO4 content (P = 0.0001). Conclusions Our animal experiment revealed that high-dose ZOL inhibited VC, but low-dose ZOL did not significantly inhibit VC. Our meta-analysis of human studies revealed that N-BP was not effective in the treatment of VC, but our meta-analysis of animal studies suggested a role of N-BP in inhibiting VC.https://doi.org/10.1186/s12872-025-04526-wNitrogen-containing bisphosphonateVascular calcificationAnimal experimentsMeta-analysis
spellingShingle Wei Xu
Guoyuan Lu
Lifeng Gong
Weigang Tang
Wei Jiang
Nitrogen-containing bisphosphonate for vascular calcification: animal experiments, systematic review and meta-analysis
BMC Cardiovascular Disorders
Nitrogen-containing bisphosphonate
Vascular calcification
Animal experiments
Meta-analysis
title Nitrogen-containing bisphosphonate for vascular calcification: animal experiments, systematic review and meta-analysis
title_full Nitrogen-containing bisphosphonate for vascular calcification: animal experiments, systematic review and meta-analysis
title_fullStr Nitrogen-containing bisphosphonate for vascular calcification: animal experiments, systematic review and meta-analysis
title_full_unstemmed Nitrogen-containing bisphosphonate for vascular calcification: animal experiments, systematic review and meta-analysis
title_short Nitrogen-containing bisphosphonate for vascular calcification: animal experiments, systematic review and meta-analysis
title_sort nitrogen containing bisphosphonate for vascular calcification animal experiments systematic review and meta analysis
topic Nitrogen-containing bisphosphonate
Vascular calcification
Animal experiments
Meta-analysis
url https://doi.org/10.1186/s12872-025-04526-w
work_keys_str_mv AT weixu nitrogencontainingbisphosphonateforvascularcalcificationanimalexperimentssystematicreviewandmetaanalysis
AT guoyuanlu nitrogencontainingbisphosphonateforvascularcalcificationanimalexperimentssystematicreviewandmetaanalysis
AT lifenggong nitrogencontainingbisphosphonateforvascularcalcificationanimalexperimentssystematicreviewandmetaanalysis
AT weigangtang nitrogencontainingbisphosphonateforvascularcalcificationanimalexperimentssystematicreviewandmetaanalysis
AT weijiang nitrogencontainingbisphosphonateforvascularcalcificationanimalexperimentssystematicreviewandmetaanalysis